Arkolith/Insider Trading/OTLC/Form 4

Trieu Vuong

CHAIRMAN AND CEO, Director, 10% OwnerOncotelic Therapeutics, Inc. (OTLC) · full profile →Form 4 · filed Jul 16, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
4 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 8, 2021Grant(A)259K—$090.5M
Mar 31, 2021Conversion(C)13.8M——16.8M
Mar 31, 2021Conversion(C)74.5M——90.3M
Mar 31, 2021Conversion(C)5.7M——6.9M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 8, 2021Grant(A)514K—$0514K
Mar 31, 2021Conversion(C)74K——0
Mar 31, 2021Conversion(C)6K——0
Mar 31, 2021Conversion(C)14K——0

Transaction Codes

A
Grant / award
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-21-017106) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML